Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome

World Journal of Gastroenterology

Volumn 20, Issue 24, 2014, Pages 7570-7586

  Muscatello, Maria Rosaria A ^a   Bruno, Antonio ^a   Scimeca, Giuseppe ^a   Pandolfo, Gianluca ^a   Zoccali, Rocco A ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Anger; Anxiety; Brain gut axis; Depression; Hypothalamic pituitary adrenal axis; Irritable bowel syndrome; Microbiota; Mood disorders; Neuroticism; Stress

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CORTICOTROPIN RELEASING FACTOR; PSYCHOTROPIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

AFFECT; ANGER; ANXIETY; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CELLULAR IMMUNITY; CHILDHOOD; CLINICAL TRIAL (TOPIC); COLON MOTILITY; COMORBIDITY; DEPRESSION; DYSBIOSIS; EMOTION; EPIGENETICS; GENERALIZED ANXIETY DISORDER; HELP SEEKING BEHAVIOR; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; INFLAMMATION; INTESTINE FLORA; IRRITABLE COLON; MALADJUSTMENT; MENTAL DISEASE; META ANALYSIS (TOPIC); MOOD DISORDER; NONHUMAN; PAIN; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSORIMOTOR FUNCTION; TEMPERAMENT; BRAIN; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INNERVATION; INTESTINE; IRRITABLE BOWEL SYNDROME; MENTAL STRESS; PATHOPHYSIOLOGY; PROGNOSIS; PSYCHOLOGY; RISK FACTOR;

AFFECT; ANGER; ANXIETY; AUTONOMIC NERVOUS SYSTEM; BRAIN; COMORBIDITY; DEPRESSION; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTESTINES; IRRITABLE BOWEL SYNDROME; PITUITARY-ADRENAL SYSTEM; PROGNOSIS; RISK FACTORS; STRESS, PSYCHOLOGICAL; TEMPERAMENT;

EID: 84903214686     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i24.7570     Document Type: Article

References (157)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroen-terology 2006; 130: 1480-1491 [PMID: 16678561 DOI: 10.1053/ j.gastro.2005.11.061]
2. Talley NJ, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease? Lancet 2002; 360: 555-564 [PMID: 12241674 DOI: 10.1016/S0140-6736(02)09712-X]
3. Clarke G, Quigley EM, Cryan JF, Dinan TG. Irritable bowel syndrome: towards biomarker identification. Trends Mol Med 2009; 15: 478-489 [PMID: 19811951 DOI: 10.1016/ j.molmed.2009.08.001]
4. Spiller RC. Postinfectious irritable bowel syndrome. Gas-troenterology 2003; 124: 1662-1671 [PMID: 12761724 DOI: 10.1016/S0016-5085(03)00324-X]
5. Guilarte M, Santos J, de Torres I, Alonso C, Vicario M, Ramos L, Martínez C, Casellas F, Saperas E, Malagelada JR. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 2007; 56: 203-209 [PMID: 17005763]
6. Akbar A, Yiangou Y, Facer P, Walters JR, Anand P, Ghosh S. Increased capsaicin receptor TRPV1-expressing sensory fbres in irritable bowel syndrome and their correlation with abdominal pain. Gut 2008; 57: 923-929 [PMID: 18252749 DOI: 10.1136/gut.2007.138982]
7. Barbara G, Cremon C, Carini G, Bellacosa L, Zecchi L, De Giorgio R, Corinaldesi R, Stanghellini V. The immune system in irritable bowel syndrome. J Neurogastroenterol Motil 2011; 17: 349-359 [PMID: 22148103 DOI: 10.5056/ jnm.2011.17.4.349]
8. Buhner S, Li Q, Vignali S, Barbara G, De Giorgio R, Stang-Hellini V, Cremon C, Zeller F, Langer R, Daniel H, Michel K, Schemann M. Activation of human enteric neurons by super-natants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology 2009; 137: 1425-1434 [PMID: 19596012 DOI: 10.1053/j.gastro.2009.07.005]
9. Gwee KA. Irritable bowel syndrome in developing coun-tries--a disorder of civilization or colonization? Neurogas-troenterol Motil 2005; 17: 317-324 [PMID: 15916618 DOI: 10.1111/j.1365-2982.2005.00627.x]
10. Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000; 46: 78-82 [PMID: 10601059 DOI: 10.1136/gut.46.1.78]
11. Whitehead WE, Schuster MM. Gastrointestinal disorders: behavioral and physiological basis for treatment. Orlando: Academic Press, 1985: 256-303
12. Saito YA, Schoenfeld P, Locke GR. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002; 97: 1910-1915 [PMID: 12190153 DOI: 10.1111/j.1572-0241.2002.05913.x]
13. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Müller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999; 45 Suppl 2: II43-II47 [PMID: 10457044 DOI: 10.1136/gut.45.2008.ii43]
14. Adeyemo MA, Spiegel BM, Chang L. Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? Aliment Pharmacol Ther 2010; 32: 738-755 [PMID: 20662786 DOI: 10.1111/j.1365-2036.2010.04409.x]
15. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569-1580 [PMID: 8359066 DOI: 10.1007/BF01303162]
16. Hahn B, Watson M, Yan S, Gunput D, Heuijerjans J. Irritable bowel syndrome symptom patterns: frequency, duration, and severity. Dig Dis Sci 1998; 43: 2715-2718 [PMID: 9881504 DOI: 10.1023/A:1026663613695]
17. Janssen HA, Muris JW, Knotterus JA. The clinical course and prognostic determinants of the irritable bowel syndrome: a literature review. Scand J Gastroenterol 1998; 33: 561-567 [PMID: 9669623 DOI: 10.1080/00365529850171783]
18. Mayer EA, Aziz Q, Coen S, Kern M, Labus JS, Lane R, Kuo B, Naliboff B, Tracey I. Brain imaging approaches to the study of functional GI disorders: a Rome working team report. Neurogastroenterol Motil 2009; 21: 579-596 [PMID: 19646070 DOI: 10.1111/j.1365-2982.2009.01304.x]
19. Elsenbruch S. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms. Brain Behav Immun 2011; 25: 386-394 [PMID: 21094682 DOI: 10.1016/j.bbi.2010.11.010]
20. Philpott H, Gibson P, Thien F. Irritable bowel syndrome - An inflammatory disease involving mast cells. Asia Pac Allergy 2011; 1: 36-42 [PMID: 22053295 DOI: 10.5415/apal-lergy.2011.1.1.36]
21. Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut 2004; 53: 1459-1464 [PMID: 15361495 DOI: 10.1136/gut.2003.037697]
22. Jeffery IB, Quigley EM, Öhman L, Simrén M, O'Toole PW. The microbiota link to irritable bowel syndrome: an emerging story. Gut Microbes 2012; 3: 572-576 [PMID: 22895081 DOI: 10.4161/gmic.21772]
23. Aziz Q, Doré J, Emmanuel A, Guarner F, Quigley EM. Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterol Motil 2013; 25: 4-15 [PMID: 23279728 DOI: 10.1111/nmo.12046]
24. Aggarwal A, Cutts TF, Abell TL, Cardoso S, Familoni B, Bremer J, Karas J. Predominant symptoms in irritable bowel syndrome correlate with specifc autonomic nervous system abnormalities. Gastroenterology 1994; 106: 945-950 [PMID: 8143999]
25. Berman S, Suyenobu B, Naliboff BD, Bueller J, Stains J, Wong H, Mandelkern M, Fitzgerald L, Ohning G, Gupta A, Labus JS, Tillisch K, Mayer EA. Evidence for alterations in central noradrenergic signaling in irritable bowel syndrome. Neuroimage 2012; 63: 1854-1863 [PMID: 22917679 DOI: 10.1016/j.neuroimage.2012.08.028]
26. Dinan TG, Clarke G, Quigley EM, Scott LV, Shanahan F, Cryan J, Cooney J, Keeling PW. Enhanced cholinergic-mediated increase in the pro-infammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. Am J Gastroenterol 2008; 103: 2570-2576 [PMID: 18785949 DOI: 10.1111/j.1572-0241.2008.01871.x]
27. Konturek PC, Brzozowski T, Konturek SJ. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol 2011; 62: 591-599 [PMID: 22314561]
28. Mulak A, Bonaz B. Irritable bowel syndrome: a model of the brain-gut interactions. Med Sci Monit 2004; 10: RA55-RA62 [PMID: 15260348]
29. Mach T. The brain-gut axis in irritable bowel syndrome-clinical aspects. Med Sci Monit 2004; 10: RA125-RA131 [PMID: 15173682]
30. Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med 2011; 62: 381-396 [PMID: 21090962 DOI: 10.1146/annurev-med-012309-103958]
31. Ohman L, Simrén M. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis 2007; 39: 201-215 [PMID: 17267314 DOI: 10.1016/ j.dld.2006.10.014]
32. Engel GL. The clinical application of the biopsychosocial model. Am J Psychiatry 1980; 137: 535-544 [PMID: 7369396]
33. Tanaka Y, Kanazawa M, Fukudo S, Drossman DA. Biopsy-chosocial model of irritable bowel syndrome. J Neurogastroen-terol Motil 2011; 17: 131-139 [PMID: 21602989 DOI: 10.5056/ jnm.2011.17.2.131]
34. Surdea-Blaga T, Bǎban A, Dumitrascu DL. Psychosocial determinants of irritable bowel syndrome. World J Gastroen-terol 2012; 18: 616-626 [PMID: 22363132 DOI: 10.3748/wjg. v18.i7.616]
35. Kerber KJ, de Graft-Johnson JE, Bhutta ZA, Okong P, Starrs A, Lawn JE. Continuum of care for maternal, newborn, and child health: from slogan to service delivery. Lancet 2007; 370: 1358-1369 [PMID: 17933651 DOI: 10.1016/ S0140-6736(07)61578-5]
36. Caldji C, Diorio J, Meaney MJ. Variations in maternal care in infancy regulate the development of stress reactivity. Biol Psychiatry 2000; 48: 1164-1174 [PMID: 11137058 DOI: 10.1016/S0006-3223(00)01084-2]
37. Champagne FA, Francis DD, Mar A, Meaney MJ. Variations in maternal care in the rat as a mediating influence for the effects of environment on development. Physiol Behav 2003; 79: 359-371 [PMID: 12954431 DOI: 10.1016/ S0031-9384(03)00149-5]
38. O'Mahony SM, Marchesi JR, Scully P, Codling C, Ceolho AM, Quigley EM, Cryan JF, Dinan TG. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 2009; 65: 263-267 [PMID: 18723164 DOI: 10.1016/ j.biopsych.2008.06.026]
39. Mayer EA, Collins SM. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 2002; 122: 2032-2048 [PMID: 12055608 DOI: 10.1053/ gast.2002.33584]
40. Davidson RJ. Affective neuroscience and psychophysiol-ogy: toward a synthesis. Psychophysiology 2003; 40: 655-665 [PMID: 14696720 DOI: 10.1111/1469-8986.00067]
41. Dalgleish T. The emotional brain. Nat Rev Neurosci 2004; 5: 583-589 [PMID: 15208700 DOI: 10.1038/nrn1432]
42. Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biol Psychiatry 2003; 54: 504-514 [PMID: 12946879 DOI: 10.1016/S0006-3223(03)00168-9]
43. Watson D, Clark LA. Negative affectivity: the disposition to experience aversive emotional states. Psychol Bull 1984; 96: 465-490 [PMID: 6393179 DOI: 10.1037/0033-2909.96.3.465]
44. Watson D, Tellegen A. Toward a consensual structure of mood. Psychol Bull 1985; 98: 219-235 [PMID: 3901060 DOI: 10.1037/0033-2909.98.2.219]
45. Clark LA, Watson D, Leeka J. Diurnal variation in the positive affects. Motiv Emot 1989; 13: 205-234 [DOI: 10.1007/ BF00995536]
46. Suls J. Affect, stress and personality. In Forgas JP. Handbook of affect and social cognition. Mahwah, NJ: Erlbaum, 2001: 392-409
47. Clark LA, Watson D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol 1991; 100: 316-336 [PMID: 1918611 DOI: 10.1037/0021-843X.100.3.316]
48. Zautra AJ, Potter PT, Reich JW. The independence of affects is context-dependent: An integrative model of the relationship between positive and negative affect. In Powell Lawton M, Warner Schaie K. Annual Review of Gerontology and Geriatrics. Berlin: Springer, 1997: 75-102
49. Pressman SD, Cohen S. Does positive affect infuence health? Psychol Bull 2005; 131: 925-971 [PMID: 16351329 DOI: 10.1037 /0033-2909.131.6.925]
50. Costa PT, McCrae RR. Neuroticism, somatic complaints, and disease: is the bark worse than the bite? J Pers 1987; 55: 299-316 [PMID: 3612472 DOI: 10.1111/j.1467-6494.1987. tb00438.x]
51. Farnam A, Somi MH, Sarami F, Farhang S, Yasrebinia S. Personality factors and profles in variants of irritable bowel syndrome. World J Gastroenterol 2007; 13: 6414-6418 [PMID: 18081232 DOI: 10.3748/wjg.13.6414]
52. Tayama J, Nakaya N, Hamaguchi T, Tomiie T, Shinozaki M, Saigo T, Shirabe S, Fukudo S. Effects of personality traits on the manifestations of irritable bowel syndrome. Biopsychosoc Med 2012; 6: 20 [PMID: 23110762 DOI: 10.1186/1751-0759-6-20]
53. Denollet J. Type D personality. A potential risk factor refined. J Psychosom Res 2000; 49: 255-266 [PMID: 11119782 DOI: 10.1016/S0022-3999(00)00177-X]
54. Denollet J. DS14: standard assessment of negative affectiv-ity, social inhibition, and Type D personality. Psychosom Med 2005; 67: 89-97 [PMID: 15673629 DOI: 10.1097/01. psy.0000149256.81953.49]
55. Chapman B, Duberstein P, Lyness JM. Personality traits, education, and health-related quality of life among older adult primary care patients. J Gerontol B Psychol Sci Soc Sci 2007; 62: P343-P352 [PMID: 18079419 DOI: 10.1093/geronb/ 62.6.P343]
56. Rothbart MK, Bates JE. Temperament in children's development. In Eisenberg n, Damon W, Lerner RM. Handbook of child psychology (6th ed.). Social, emotional, and personality development. New York: John Wiley & Sons, 2006: 99-166
57. Kagan J. Temperament and the reactions to unfamiliarity. Child Dev 1997; 68: 139-143 [PMID: 9084130 DOI: 10.1111/ j.1467-8624.1997.tb01931.x]
58. Muris P, van Brakel AM, Arntz A, Schouten E. Behavioral Inhibition as a Risk Factor for the Development of Childhood Anxiety Disorders: A Longitudinal Study. J Child Fam Stud 2011; 20: 157-170 [PMID: 21475710 DOI: 10.1007/ s10826-010-9365-8]
59. Wood AM, Joseph S. The absence of positive psychological (eudemonic) well-being as a risk factor for depression: a ten year cohort study. J Affect Disord 2010; 122: 213-217 [PMID: 19706357 DOI: 10.1016/j.jad.2009.06.032]
60. Cirulli F, Laviola G, Ricceri L. Risk factors for mental health: translational models from behavioural neuroscience. Neu-rosci Biobehav Rev 2009; 33: 493-497 [PMID: 19415818 DOI: 10.1016/j.neubiorev.2009.01.006]
61. Probst AV, Dunleavy E, Almouzni G. Epigenetic inheritance during the cell cycle. Nat Rev Mol Cell Biol 2009; 10: 192-206 [PMID: 19234478 DOI: 10.1038/nrm2640]
62. Suderman M, McGowan PO, Sasaki A, Huang TC, Hal-lett MT, Meaney MJ, Turecki G, Szyf M. Conserved epi-genetic sensitivity to early life experience in the rat and human hippocampus. Proc Natl Acad Sci USA 2012; 109 Suppl 2: 17266-17272 [PMID: 23045659 DOI: 10.1073/ pnas.1121260109]
63. Francis D, Diorio J, Liu D, Meaney MJ. Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science 1999; 286: 1155-1158 [PMID: 10550053 DOI: 10.1126/science.286.5442.1155]
64. Gilbert R, Widom CS, Browne K, Fergusson D, Webb E, Janson S. Burden and consequences of child maltreatment in high-income countries. Lancet 2009; 373: 68-81 [PMID: 19056114 DOI: 10.1016/S0140-6736(08)61706-7]
65. Tojek TM, Lumley MA, Corlis M, Ondersma S, Tolia V. Maternal correlates of health status in adolescents with in-fammatory bowel disease. J Psychosom Res 2002; 52: 173-179 [PMID: 11897236 DOI: 10.1016/S0022-3999(01)00291-4]
66. Rosmalen JG, Neeleman J, Gans RO, de Jonge P. The association between neuroticism and self-reported common somatic symptoms in a population cohort. J Psychosom Res 2007; 62: 305-311 [PMID: 17324681 DOI: 10.1016/j.jpsychore s.2006.10.014]
67. Holstege G, Bandler R, Saper CB. The Emotional Motor System. In: Jones EG, Peters A. Progress in brain research Vol. 107. Amsterdam: Elsevier, 1996: 3-6
68. Muscatello MR, Bruno A, Pandolfo G, Micò U, Stilo S, Scaf-fdi M, Consolo P, Tortora A, Pallio S, Giacobbe G, Familiari L, Zoccali R. Depression, anxiety and anger in subtypes of irritable bowel syndrome patients. J Clin Psychol Med Settings 2010; 17: 64-70 [PMID: 20094761 DOI: 10.1007/ s10880-009-9182-7]
69. Seminowicz DA, Labus JS, Bueller JA, Tillisch K, Naliboff BD, Bushnell MC, Mayer EA. Regional gray matter density changes in brains of patients with irritable bowel syndrome. Gastroenterology 2010; 139: 48-57e2 [PMID: 20347816 DOI: 10.1053/j.gastro.2010.03.049]
70. Brown TA, Chorpita BF, Barlow DH. Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal. J Abnorm Psychol 1998; 107: 179-192 [PMID: 9604548 DOI: 10.1037/0021-843X.107.2.179]
71. Ng C, Malcolm A, Hansen R, Kellow J. Feeding and colonic distension provoke altered autonomic responses in irritable bowel syndrome. Scand J Gastroenterol 2007; 42: 441-446 [PMID: 17454853 DOI: 10.1080/00365520600965749]
72. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 2011; 12: 453-466 [PMID: 21750565 DOI: 10.1038/nrn3071]
73. Stephens RL, Tache Y. Intracisternal injection of a TRH analogue stimulates gastric luminal serotonin release in rats. Am J Physiol 1989; 256: G377-G383 [PMID: 2493198]
74. Selye H. A syndrome produced by diverse nocuous agents. 1936. J Neuropsychiatry Clin Neurosci 1998; 10: 230-231 [PMID: 9722327]
75. Swaab DF. The human hypothalamus. Basic and clinical aspects. Part I: Nuclei of the hypothalamus. In: Aminoff MJ, Boller F, Swaab DF. Handbook of Clinical Neurology, vol. 79. Amsterdam: Elsevier, 2003: 1-476
76. Rivest S. How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 2001; 26: 761-788 [PMID: 11585678 DOI: 10.1016/S0306-4530(01)00064-6]
77. Stengel A, Taché Y. Corticotropin-releasing factor signaling and visceral response to stress. Exp Biol Med (Maywood) 2010; 235: 1168-1178 [PMID: 20881321 DOI: 10.1258/ ebm.2010.009347]
78. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Mon-teggia LM. Neurobiology of depression. Neuron 2002; 34: 13-25 [PMID: 11931738 DOI: 10.1016/S0896-6273(02)00653-0]
79. Rao U, Chen LA, Bidesi AS, Shad MU, Thomas MA, Hammen CL. Hippocampal changes associated with early-life adversity and vulnerability to depression. Biol Psychiatry 2010; 67: 357-364 [PMID: 20015483 DOI: 10.1016/j.biopsych.2009.10.017]
80. Wardenaar KJ, Vreeburg SA, van Veen T, Giltay EJ, Veen G, Penninx BW, Zitman FG. Dimensions of depression and anxiety and the hypothalamo-pituitary-adrenal axis. Biol Psychiatry 2011; 69: 366-373 [PMID: 21030010 DOI: 10.1016/ j.biopsych.2010.09.005]
81. Buchanan TW, Al'Absi M, Lovallo WR. Cortisol fuctuates with increases and decreases in negative affect. Psychoneuro-endocrinology 1999; 24: 227-241 [PMID: 10101730]
82. Chang L, Sundaresh S, Elliott J, Anton PA, Baldi P, Licudine A, Mayer M, Vuong T, Hirano M, Naliboff BD, Ameen VZ, Mayer EA. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neuro-gastroenterol Motil 2009; 21: 149-159 [PMID: 18684212 DOI: 10.1111/j.1365-2982.2008.01171.x]
83. Drossman DA. Abuse, trauma, and GI illness: is there a link? Am J Gastroenterol 2011; 106: 14-25 [PMID: 21139573 DOI: 10.1038/ajg.2010.453]
84. Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol 2009; 5: 374-381 [PMID: 19488073 DOI: 10.1038/nrendo.2009.106]
85. O'Mahony SM, Hyland NP, Dinan TG, Cryan JF. Maternal separation as a model of brain-gut axis dysfunction. Psycho-pharmacology (Berl) 2011; 214: 71-88 [PMID: 20886335 DOI: 10.1007/s00213-010-2010-9]
86. Kemeny ME, Schedlowski M. Understanding the interaction between psychosocial stress and immune-related diseases: a stepwise progression. Brain Behav Immun 2007; 21: 1009-1018 [PMID: 17889502 DOI: 10.1016/j.bbi.2007.07.010]
87. Dockray S, Steptoe A. Positive affect and psychobiologi-cal processes. Neurosci Biobehav Rev 2010; 35: 69-75 [PMID: 20097225 DOI: 10.1016/j.neubiorev.2010.01.006]
88. Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Psycho-neuroimmunology: psychological influences on immune function and health. J Consult Clin Psychol 2002; 70: 537-547 [PMID: 12090368 DOI: 10.1037/0022-006X.70.3.537]
89. Christensen AJ, Edwards DL, Wiebe JS, Benotsch EG, McK-elvey L, Andrews M, Lubaroff DM. Effect of verbal self-disclosure on natural killer cell activity: moderating infuence of cynical hostility. Psychosom Med 1996; 58: 150-155 [PMID: 8849632 DOI: 10.1007/s12160-008-9041-z]
90. Maes M, Mihaylova I, Kubera M, Ringel K. Activation of cell-mediated immunity in depression: association with infammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression. Prog Neuro-psychopharmacol Biol Psychiatry 2012; 36: 169-175 [PMID: 21945535 DOI: 10.1016/j.pnpbp.2011.09.006]
91. Blume J, Douglas SD, Evans DL. Immune suppression and immune activation in depression. Brain Behav Immun 2011; 25: 221-229 [PMID: 20955778 DOI: 10.1016/j.bbi.2010.10.008]
92. Clarke G, Fitzgerald P, Hennessy AA, Cassidy EM, Quigley EM, Ross P, Stanton C, Cryan JF, Dinan TG. Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome. J Lipid Res 2010; 51: 1186-1192 [PMID: 19965606 DOI: 10.1194/jlr. P000695]
93. Piche T, Saint-Paul MC, Dainese R, Marine-Barjoan E, Ian-nelli A, Montoya ML, Peyron JF, Czerucka D, Cherikh F, Filippi J, Tran A, Hébuterne X. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut 2008; 57: 468-473 [PMID: 18194987 DOI: 10.1136/gut.2007.127068]
94. Folks DG. The interface of psychiatry and irritable bowel syndrome. Curr Psychiatry Rep 2004; 6: 210-215 [PMID: 15142474 DOI: 10.1007/s11920-004-0066-0]
95. Guthrie E, Creed F, Fernandes L, Ratcliffe J, Van Der Jagt J, Martin J, Howlett S, Read N, Barlow J, Thompson D, To-menson B. Cluster analysis of symptoms and health seeking behaviour differentiates subgroups of patients with severe irritable bowel syndrome. Gut 2003; 52: 1616-1622 [PMID: 14570732 DOI: 10.1136/gut.52.11.1616]
96. Whitehead WE, Palsson OS, Levy RR, Feld AD, Turner M, Von Korff M. Comorbidity in irritable bowel syndrome. Am J Gastroenterol 2007; 102: 2767-2776 [PMID: 17900326 DOI: 10.1111/j.1572-0241.2007.01540.x]
97. Locke GR, Weaver AL, Melton LJ, Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gas-troenterol 2004; 99: 350-357 [PMID: 15046228 DOI: 10.1111/ j.1572-0241.2004.04043.x]
98. Shen L, Kong H, Hou X. Prevalence of irritable bowel syndrome and its relationship with psychological stress status in Chinese university students. J Gastroenterol Hepa-tol 2009; 24: 1885-1890 [PMID: 19780881 DOI: 10.1111/ j.1440-1746.2009.05943.x]
99. Choung RS, Locke GR, Zinsmeister AR, Schleck CD, Talley NJ. Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule. Am J Gastroenterol 2009; 104: 1772-1779 [PMID: 19491833 DOI: 10.1038/ajg.2009.239]
100. Drossman DA, Chang L. Psychosocial factors in the care of patients with GI disorders. In: Yamada T. Textbook of gas-troenterology. Philadelphia: Lippincott-Raven, 2003: 636-654
101. Mussell M, Kroenke K, Spitzer RL, Williams JB, Herzog W, Löwe B. Gastrointestinal symptoms in primary care: prevalence and association with depression and anxiety. J Psychosom Res 2008; 64: 605-612 [PMID: 18501261 DOI: 10.1016/j.jpsychores.2008.02.019]
102. Haug TT, Mykletun A, Dahl AA. Are anxiety and depression related to gastrointestinal symptoms in the general population? Scand J Gastroenterol 2002; 37: 294-298 [PMID: 11916191 DOI: 10.1080/003655202317284192]
103. Lee S, Wu J, Ma YL, Tsang A, Guo WJ, Sung J. Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study. Aliment Pharmacol Ther 2009; 30: 643-651 [PMID: 19552631 DOI: 10.1111/j.1365-2036.2009.04074.x]
104. North CS, Hong BA, Alpers DH. Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment. World J Gastroenterol 2007; 13: 2020-2027 [PMID: 17465442]
105. Levy RL, Whitehead WE, Von Korff MR, Feld AD. Intergen-erational transmission of gastrointestinal illness behavior. Am J Gastroenterol 2000; 95: 451-456 [PMID: 10685749 DOI: 10.1111/j.1572-0241.2000.01766.x]
106. Garakani A, Win T, Virk S, Gupta S, Kaplan D, Masand PS. Comorbidity of irritable bowel syndrome in psychiatric patients: a review. Am J Ther 2003; 10: 61-67 [PMID: 12522523 DOI: 10.1097/00045391-200301000-00014]
107. Masand PS, Kaplan DS, Gupta S, Bhandary AN. Relationship between irritable bowel syndrome (IBS) and double depression (dysthymia plus major depression). Depression 1995; 3: 303-308 [DOI: 10.1002/depr.3050030608]
108. Gros DF, Antony MM, McCabe RE, Swinson RP. Frequency and severity of the symptoms of irritable bowel syndrome across the anxiety disorders and depression. J Anxiety Disord 2009; 23: 290-296 [PMID: 18819774 DOI: 10.1016/j.janxdis.2008.08.004]
109. Santor DA, Coyne JC. Evaluating the continuity of symptomatology between depressed and nondepressed individuals. J Abnorm Psychol 2001; 110: 216-225 [PMID: 11358016 DOI: 10.1037/0021-843X.110.2.216]
110. Cohen S, Rodriquez MS. Pathways linking affective disturbances and physical disorders. Health Psychol 1995; 14: 374-380 [PMID: 7498107 DOI: 10.1037/0278-6133.14.5.374]
111. Ritchie J. Pain from distension of the pelvic colon by infat-ing a balloon in the irritable colon syndrome. Gut 1973; 14: 125-132 [PMID: 4696535]
112. Mayer EA, Bradesi S, Chang L, Spiegel BM, Bueller JA, Na-liboff BD. Functional GI disorders: from animal models to drug development. Gut 2008; 57: 384-404 [PMID: 17965064 DOI: 10.1136/gut.2006.101675]
113. Dorn SD, Palsson OS, Thiwan SI, Kanazawa M, Clark WC, van Tilburg MA, Drossman DA, Scarlett Y, Levy RL, Rin-gel Y, Crowell MD, Olden KW, Whitehead WE. Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity. Gut 2007; 56: 1202-1209 [PMID: 17483191 DOI: 10.1136/gut.2006.117390]
114. Chapman S, Martin M. Attention to pain words in irritable bowel syndrome: increased orienting and speeded engagement. Br J Health Psychol 2011; 16: 47-60 [PMID: 21226783 DOI: 10.1348/135910710X505887]
115. Walter SA, Jones MP, Talley NJ, Kjellström L, Nyhlin H, Andreasson AN, Agréus L. Abdominal pain is associated with anxiety and depression scores in a sample of the general adult population with no signs of organic gastrointestinal disease. Neurogastroenterol Motil 2013; 25: 741-e576 [PMID: 23692044 DOI: 10.1111/nmo.12155]
116. de Medeiros MT, Carvalho AF, de Oliveira Lima JW, Dos Santos AA, de Oliveira RB, Nobre E Souza MA. Impact of depressive symptoms on visceral sensitivity among patients with different subtypes of irritable bowel syndrome. J Nerv Ment Dis 2008; 196: 711-714 [PMID: 18791434 DOI: 10.1097/ NMD.0b013e318183f896]
117. van der Veek PP, Van Rood YR, Masclee AA. Symptom severity but not psychopathology predicts visceral hyper-sensitivity in irritable bowel syndrome. Clin Gastroenterol Hepatol 2008; 6: 321-328 [PMID: 18258487 DOI: 10.1016/ j.cgh.2007.12.005]
118. Rosenberger C, Elsenbruch S, Scholle A, de Greiff A, Sched-lowski M, Forsting M, Gizewski ER. Effects of psychological stress on the cerebral processing of visceral stimuli in healthy women. Neurogastroenterol Motil 2009; 21: 740-e45 [PMID: 19368654 DOI: 10.1111/j.1365-2982.2009.01295.x]
119. Tillisch K, Labus JS. Advances in imaging the brain-gut axis: functional gastrointestinal disorders. Gastroenterol-ogy 2011; 140: 407-411e1 [PMID: 21167161 DOI: 10.1053/ j.gastro.2010.12.014]
120. Elsenbruch S, Rosenberger C, Enck P, Forsting M, Sched-lowski M, Gizewski ER. Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study. Gut 2010; 59: 489-495 [PMID: 19651629 DOI: 10.1136/gut.2008.175000]
121. Hazlett-Stevens H, Craske MG, Mayer EA, Chang L, Nali-boff BD. Prevalence of irritable bowel syndrome among university students: the roles of worry, neuroticism, anxiety sensitivity and visceral anxiety. J Psychosom Res 2003; 55: 501-505 [PMID: 14642979 DOI: 10.1016/S0022-3999(03)00019-9]
122. Bouchoucha M, Hejnar M, Devroede G, Babba T, Bon C, Benamouzig R. Anxiety and depression as markers of multiplicity of sites of functional gastrointestinal disorders: a gender issue? Clin Res Hepatol Gastroenterol 2013; 37: 422-430 [PMID: 23270854 DOI: 10.1016/j.clinre.2012.10.011]
123. Welgan P, Meshkinpour H, Beeler M. Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome. Gastroenterology 1988; 94: 1150-1156 [PMID: 3350284]
124. Welgan P, Meshkinpour H, Ma L. Role of anger in antral motor activity in irritable bowel syndrome. Dig Dis Sci 2000; 45: 248-251 [PMID: 10711433 DOI: 10.1023/A:1005487821063]
125. Bennett EJ, Evans P, Scott AM, Badcock CA, Shuter B, Höschl R, Tennant CC, Kellow JE. Psychological and sex features of delayed gut transit in functional gastrointestinal disorders. Gut 2000; 46: 83-87 [PMID: 10601060 DOI: 10.1136/ gut.46.1.83]
126. Evans PR, Bennett EJ, Bak YT, Tennant CC, Kellow JE. Jeju-nal sensorimotor dysfunction in irritable bowel syndrome: clinical and psychosocial features. Gastroenterology 1996; 110: 393-404 [PMID: 8566585 DOI: 10.1053/gast.1996.v110. pm8566585]
127. Zoccali R, Muscatello MR, Bruno A, Barillà G, Campolo D, Meduri M, Familiari L, Bonica M, Consolo P, Scaffidi M. Anger and ego-defence mechanisms in non-psychiatric patients with irritable bowel syndrome. Dig Liver Dis 2006; 38: 195-200 [PMID: 16500602]
128. Beesley H, Rhodes J, Salmon P. Anger and childhood sexual abuse are independently associated with irritable bowel syndrome. Br J Health Psychol 2010; 15: 389-399 [PMID: 19691916 DOI: 10.1348/135910709X466496]
129. Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 2009; 136: 2003-2014 [PMID: 19457424 DOI: 10.1053/j.gastro.2009.01.075]
130. Codling C, O'Mahony L, Shanahan F, Quigley EM, Marchesi JR. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci 2010; 55: 392-397 [PMID: 19693670 DOI: 10.1007/s10620-009-0934-x]
131. Grover M, Kanazawa M, Palsson OS, Chitkara DK, Ganga-rosa LM, Drossman DA, Whitehead WE. Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress. Neurogastroenterol Motil 2008; 20: 998-1008 [PMID: 18482250 DOI: 10.1111/j.1365-2982.2008.01142.x]
132. Reigstad CS, Kashyap PC. Beyond phylotyping: understanding the impact of gut microbiota on host biology. Neu-rogastroenterol Motil 2013; 25: 358-372 [PMID: 23594242]
133. Park AJ, Collins J, Blennerhassett PA, Ghia JE, Verdu EF, Bercik P, Collins SM. Altered colonic function and micro-biota profle in a mouse model of chronic depression. Neuro-gastroenterol Motil 2013; 25: 733-e575 [PMID: 23773726 DOI: 10.1111/nmo.12153]
134. Jeffery IB, O'Toole PW, Öhman L, Claesson MJ, Deane J, Quigley EM, Simrén M. An irritable bowel syndrome subtype defned by species-specifc alterations in faecal micro-biota. Gut 2012; 61: 997-1006 [PMID: 22180058 DOI: 10.1136/ gutjnl-2011-301501]
135. Al-Khatib K, Lin HC. Immune activation and gut microbes in irritable bowel syndrome. Gut Liver 2009; 3: 14-19 [PMID: 20479895 DOI: 10.5009/gnl.2009.3.1.14]
136. Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, Wilson I. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002; 122: 1778-1783 [PMID: 12055584 DOI: 10.1053/gast.2002.33579]
137. Scully P, McKernan DP, Keohane J, Groeger D, Shanahan F, Dinan TG, Quigley EM. Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol 2010; 105: 2235-2243 [PMID: 20407431 DOI: 10.1038/ajg.2010.159]
138. Gao J. Correlation between anxiety-depression status and cytokines in diarrhea-predominant irritable bowel syndrome. Exp Ther Med 2013; 6: 93-96 [PMID: 23935726 DOI: 10.3892/etm.2013.1101]
139. Toker S, Shirom A, Shapira I, Berliner S, Melamed S. The association between burnout, depression, anxiety, and in-fammation biomarkers: C-reactive protein and fibrinogen in men and women. J Occup Health Psychol 2005; 10: 344-362 [PMID: 16248685 DOI: 10.1037/1076-8998.10.4.344]
140. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009; 71: 171-186 [PMID: 19188531 DOI: 10.1097/PSY.0b013e3181907c1b]
141. O'Donovan A, Hughes BM, Slavich GM, Lynch L, Cronin MT, O'Farrelly C, Malone KM. Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion-biology relationships. Brain Behav Immun 2010; 24: 1074-1077 [PMID: 20227485 DOI: 10.1016/j.bbi.2010.03.003]
142. Boylan JM, Ryff CD. Varieties of anger and the inverse link between education and inflammation: toward an integra-tive framework. Psychosom Med 2013; 75: 566-574 [PMID: 23766379 DOI: 10.1097/PSY.0b013e31829683bd]
143. Marsland AL, Prather AA, Petersen KL, Cohen S, Manuck SB. Antagonistic characteristics are positively associated with infammatory markers independently of trait negative emotionality. Brain Behav Immun 2008; 22: 753-761 [PMID: 18226879 DOI: 10.1016/j.bbi.2007.11.008]
144. Levy RL, Whitehead WE, Walker LS, Von Korff M, Feld AD, Garner M, Christie D. Increased somatic complaints and health-care utilization in children: effects of parent IBS status and parent response to gastrointestinal symptoms. Am J Gastroenterol 2004; 99: 2442-2451 [PMID: 15571594 DOI: 10.1111/j.1572-0241.2004.40478.x]
145. Videlock EJ, Adeyemo M, Licudine A, Hirano M, Ohning G, Mayer M, Mayer EA, Chang L. Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome. Gastroenterol-ogy 2009; 137: 1954-1962 [PMID: 19737564 DOI: 10.1053/ j.gastro.2009.08.058]
146. Koloski NA, Talley NJ, Boyce PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol 2001; 96: 1340-1349 [PMID: 11374666 DOI: 10.1111/j.1572-0241.2001.03789.x]
147. Cameron L, Leventhal EA, Leventhal H. Seeking medical care in response to symptoms and life stress. Psychosom Med 1995; 57: 37-47 [PMID: 7732157]
148. Gulewitsch MD, Enck P, Schwille-Kiuntke J, Weimer K, Schlarb AA. Mental Strain and Chronic Stress among University Students with Symptoms of Irritable Bowel Syndrome. Gastroenterol Res Pract 2013; 2013: 206574 [PMID: 23843782 DOI: 10.1155/2013/206574]
149. Van Oudenhove L, Aziz Q. Recent insights on central processing and psychological processes in functional gastrointestinal disorders. Dig Liver Dis 2009; 41: 781-787 [PMID: 19665954 DOI: 10.1016/j.dld.2009.07.004]
150. North CS, Downs D, Clouse RE, Alrakawi A, Dokucu ME, Cox J, Spitznagel EL, Alpers DH. The presentation of irritable bowel syndrome in the context of somatization disorder. Clin Gastroenterol Hepatol 2004; 2: 787-795 [PMID: 15354279 DOI: 10.1016/S1542-3565(04)00350-7]
151. Quartero AO, Meineche-Schmidt V, Muris J, Rubin G, de Wit N. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2005; (2): CD003460 [PMID: 15846668 DOI: 10.1002/14651858.CD003460.pub2]
152. Grover M, Drossman DA. Centrally acting therapies for irritable bowel syndrome. Gastroenterol Clin North Am 2011; 40: 183-206 [PMID: 21333907 DOI: 10.1016/j.gtc.2010.12.003]
153. Rahimi R, Nikfar S, Rezaie A, Abdollahi M. Effcacy of tri-cyclic antidepressants in irritable bowel syndrome: a meta-analysis. World J Gastroenterol 2009; 15: 1548-1553 [PMID: 19340896 DOI: 10.3748/wjg.15.1548]
154. Beattie DT, Smith JA. Serotonin pharmacology in the gastrointestinal tract: a review. Naunyn Schmiedebergs Arch Pharmacol 2008; 377: 181-203 [PMID: 18398601 DOI: 10.1007/s00210-008-0276-9]
155. Mayer EA, Tillisch K, Bradesi S. Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Aliment Pharmacol Ther 2006; 24: 919-933 [PMID: 16948804 DOI: 10.1111/j.1365-2036.2006.03078.x]
156. Salari P, Abdollahi M. Systematic review of modulators of benzodiazepine receptors in irritable bowel syndrome: is there hope? World J Gastroenterol 2011; 17: 4251-4257 [PMID: 22090780 DOI: 10.3748/wjg.v17.i38.4251]
157. Zijdenbos IL, de Wit NJ, van der Heijden GJ, Rubin G, Quartero AO. Psychological treatments for the management of irritable bowel syndrome. Cochrane Database Syst Rev 2009; (1): CD006442 [PMID: 19160286 DOI: 10.1002/14651858. CD006442.pub2]